UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 460

Sortiert nach

P23-4 Treatment outcomes of advanced gastrointestinal neuroendocrine carcinoma

Annals of oncology, 2021-07, Vol.32, p.S342-S342

Sugiyama, Keiji

2021

Volltextzugriff (PDF)

Baseline Sarcopenia and Skeletal Muscle Loss During Chemotherapy Affect Survival Outcomes in Metastatic Gastric Cancer

Anticancer research, 2018-10, Vol.38 (10), p.5859-5866

2018

Volltextzugriff (PDF)

A triplet combination of FOLFOXIRI plus cetuximab as first-line treatment in RAS wild-type, metastatic colorectal cancer: a dose-escalation phase Ib study

International journal of clinical oncology, 2021-04, Vol.26 (4), p.701-707

2021

Volltextzugriff (PDF)

A prospective survey of comprehensive score for financial toxicity in Japanese cancer patients: report on a pilot study

Ecancermedicalscience, 2018-07, Vol.12, p.847-847

2018

Volltextzugriff (PDF)

Perspective and Usage of the Clinical Guideline of Oncology from the Viewpoint of a Medical Oncologist Working at a Community Hospital

Gan to kagaku ryoho, 2023-02, Vol.50 (2), p.148

Sugiyama, Keiji

2023

Volltextzugriff (PDF)

Invasive carcinoma with neuroendocrine differentiation of the breast showing triple negative, large and basal cell‐like features

Pathology international, 2019-08, Vol.69 (8), p.502-504

2019

Volltextzugriff (PDF)

Successful Alectinib Treatment for Carcinoma of Unknown Primary with EML4-ALK Fusion Gene: A Case Report

Current oncology (Toronto), 2021-05, Vol.28 (3), p.1938-1945

2021

Volltextzugriff (PDF)

Post-marketing monitoring of intussusception after rotavirus vaccination in Japan

Pharmacoepidemiology and drug safety, 2015-07, Vol.24 (7), p.765-770

2015

Volltextzugriff (PDF)

Sarcopenia and Nutrition Support in the Treatment of Gastric Cancer

Gan to kagaku ryoho, 2020-11, Vol.47 (11), p.1542

Sugiyama, Keiji

2020

Volltextzugriff (PDF)

The impact of the Glasgow Prognostic Score on survival in second-line chemotherapy for metastatic colorectal cancer patients with BRAF V600E mutation

Therapeutic advances in medical oncology, 2019-01, Vol.11, p.1758835918820298-1758835918820298

2019

Volltextzugriff (PDF)

Successful Treatment of Cardiac Angiosarcoma Associated with Disseminated Intravascular Coagulation with Nab-Paclitaxel: A Case Report and Review of the Literature

Case reports in oncology, 2017-09, Vol.10 (3), p.863-870

2017

Volltextzugriff (PDF)

Prospective Survey of Financial Toxicity Measured by the Comprehensive Score for Financial Toxicity in Japanese Patients With Cancer

Journal of global oncology, 2019-05, Vol.5 (5), p.1-8

2019

Volltextzugriff (PDF)

Immunotherapy for Unresectable Small Bowel Adenocarcinoma: A Case Series

In vivo (Athens), 2024-01, Vol.38 (1), p.518-522

2024

Volltextzugriff (PDF)

Clinical characteristics and COVID-19-related outcomes of immunocompromised patients receiving tixagevimab/cilgavimab pre-exposure prophylaxis in Japan

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2024-07

2024

Volltextzugriff (PDF)

Safety and Complications of Medical Thoracoscopy

Advances in medicine, 2016-01, Vol.2016, p.3794791-6

2016

Volltextzugriff (PDF)

The impact of nutrition support in advanced gastric adenocarcinoma patients treated with chemotherapy

Journal of clinical oncology, 2021-01, Vol.39 (3_suppl), p.208-208

2021

Volltextzugriff (PDF)

Salvage Chemotherapy by FOLFIRI Regimen for Poorly Differentiated Gastrointestinal Neuroendocrine Carcinoma

Journal of gastrointestinal cancer, 2021-09, Vol.52 (3), p.947-951

2021

Volltextzugriff (PDF)

P42-7 FOLFOX-based chemoradiotherapy for locally advanced/metastatic esophageal squamous cell carcinoma with severe dysphagia

Annals of oncology, 2022-07, Vol.33, p.S530

2022

Volltextzugriff (PDF)

MO37-1 Treatment outcome and relapse of serious immune-related adverse events in patients with solid malignancies

Annals of oncology, 2022-07, Vol.33, p.S505

2022

Volltextzugriff (PDF)

MO43-4 The impact of nutrition support and Glasgow prognostic score in advanced gastric cancer patients treated by chemotherapy

Annals of oncology, 2022-07, Vol.33, p.S509

2022

Volltextzugriff (PDF)

O14-1 A randomized phase II study comparing S-1 plus oxaliplatin with S-1 monotherapy for elderly patients with advanced gastric cancer: WJOG8315G

Annals of oncology, 2023-11, Vol.34, p.S1390-S1390

2023

Volltextzugriff (PDF)

The Impact of Nutritional Support on Survival Outcomes in Patients with Advanced Gastric Adenocarcinoma Treated with Chemotherapy

Nutrition and cancer, 2023, Vol.75 (3), p.867-875

2023

Volltextzugriff (PDF)

Efficacy of trastuzumab deruxtecan in an advanced gastric cancer patient with brain metastasis

Current problems in cancer, 2021-12, Vol.45 (6), p.100757, Article 100757

2021

Volltextzugriff (PDF)

FOLFOX as First-line Therapy for Gastric Cancer with Severe Peritoneal Metastasis

Anticancer research, 2017-12, Vol.37 (12), p.7037-7042

2017

Volltextzugriff (PDF)

P42-5 Optimal primary prophylaxis for febrile neutropenia during docetaxel, cisplatin, and 5-FU therapy for esophageal cancer

Annals of oncology, 2022-07, Vol.33, p.S530

2022

Volltextzugriff (PDF)

1 – 25 von 460

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(386)
Mit Volltextzugriff
(426)

Publikationsform

Sprache

Englisch
(422)
Japanisch
(158)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

P23-4 Treatment outcomes of advanced gastrointestinal neuroendocrine carcinoma

Baseline Sarcopenia and Skeletal Muscle Loss During Chemotherapy Affect Survival Outcomes in Metastatic Gastric Cancer

A triplet combination of FOLFOXIRI plus cetuximab as first-line treatment in RAS wild-type, metastatic colorectal cancer: a dose-escalation phase Ib study

A prospective survey of comprehensive score for financial toxicity in Japanese cancer patients: report on a pilot study

Perspective and Usage of the Clinical Guideline of Oncology from the Viewpoint of a Medical Oncologist Working at a Community Hospital

Invasive carcinoma with neuroendocrine differentiation of the breast showing triple negative, large and basal cell‐like features

Successful Alectinib Treatment for Carcinoma of Unknown Primary with EML4-ALK Fusion Gene: A Case Report

Post-marketing monitoring of intussusception after rotavirus vaccination in Japan

Sarcopenia and Nutrition Support in the Treatment of Gastric Cancer

The impact of the Glasgow Prognostic Score on survival in second-line chemotherapy for metastatic colorectal cancer patients with BRAF V600E mutation

Successful Treatment of Cardiac Angiosarcoma Associated with Disseminated Intravascular Coagulation with Nab-Paclitaxel: A Case Report and Review of the Literature

Prospective Survey of Financial Toxicity Measured by the Comprehensive Score for Financial Toxicity in Japanese Patients With Cancer

Immunotherapy for Unresectable Small Bowel Adenocarcinoma: A Case Series

Clinical characteristics and COVID-19-related outcomes of immunocompromised patients receiving tixagevimab/cilgavimab pre-exposure prophylaxis in Japan

Safety and Complications of Medical Thoracoscopy

The impact of nutrition support in advanced gastric adenocarcinoma patients treated with chemotherapy

Salvage Chemotherapy by FOLFIRI Regimen for Poorly Differentiated Gastrointestinal Neuroendocrine Carcinoma

P42-7 FOLFOX-based chemoradiotherapy for locally advanced/metastatic esophageal squamous cell carcinoma with severe dysphagia

MO37-1 Treatment outcome and relapse of serious immune-related adverse events in patients with solid malignancies

MO43-4 The impact of nutrition support and Glasgow prognostic score in advanced gastric cancer patients treated by chemotherapy

O14-1 A randomized phase II study comparing S-1 plus oxaliplatin with S-1 monotherapy for elderly patients with advanced gastric cancer: WJOG8315G

The Impact of Nutritional Support on Survival Outcomes in Patients with Advanced Gastric Adenocarcinoma Treated with Chemotherapy

Efficacy of trastuzumab deruxtecan in an advanced gastric cancer patient with brain metastasis

FOLFOX as First-line Therapy for Gastric Cancer with Severe Peritoneal Metastasis

P42-5 Optimal primary prophylaxis for febrile neutropenia during docetaxel, cisplatin, and 5-FU therapy for esophageal cancer

Suchergebnisse filtern